Isabelle Huys

Policies for biosimilar uptake in Europe: An overview

Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 352 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmaceutical Policy +16

Quality and Safety Requirements for Sustainable Phage Therapy Products

Jean‐Paul Pirnay, Bob Blasdel, Laurent Bretaudeau et al. · Pharmaceutical Research · 2015 · 262 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains

Christine H. Rohde, Grégory Resch, Jean‐Paul Pirnay et al. · Viruses · 2018 · 205 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium

Liese Vandeborne, Eline van Overbeeke, Marc Dooms et al. · Orphanet Journal of Rare Diseases · 2019 · 179 citations · Full text

Medicine, Medical Education, Pediatrics +10

Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

Kim Pauwels, Isabelle Huys, Sabine Vogler et al. · Frontiers in Pharmacology · 2017 · 145 citations · Full text

Pharmacy, Oncology, Pharmaceutical Policy +9